Company insider dossier

Align Technology Inc insider intelligence

ALGN filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Medical Instruments & Supplies Data API
50/100

No directional read

31/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments & Supplies
Latest evidence
20 May 2026

Investment committee read

No directional read

The tape contains filings, but none provide enough priced common-share evidence for a directional classification.

Evidence is contextual

Evidence in favour

  • Participation spans 10 named insiders rather than one filing source.

Decision risks

  • Most filings are awards, derivatives, unpriced common shares, or other securities and remain contextual.
Conviction50No directional read
Confidence31Thin evidence
Named insiders10participating in the tape
Controlled events0directional common-share events
Acquisition value$0normalized amount
Disposal value$0normalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

206.77186.53166.28146.04125.79 Acquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reportedAcquisition · 20 May 2026 · Not reported
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
173.66 USD
One-week move
+2.7%
Four-week move
-3.2%
Fair-value gap
-18.3%
Trend signal
Inactive
Relative strength
-5.9

Directional balance

Controlled event mix

0%acquisition
Acquisition events
0
Disposal events
0
Net value
$0

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

025 May
001 Jun
008 Jun
015 Jun
022 Jun
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug

Named participants

Insider conviction by person

CONROY, KEVIN TDirector500 events
DALLAS, KEVIN JDirector500 events
LACOB, JOSEPHDirector500 events
LARKIN, C RAYMOND JRDirector500 events
MORROW, GEORGE JDirector500 events
MYONG, ANNEDirector500 events
POUL, MOJDEHDirector500 events
SAIA, ANDREA LYNNDirector500 events
SIEGEL, SUSAN EDirector500 events
VITALONE, BRITT J.Director500 events

Evidence quality

Security and transaction context

Common equity10
Equity compensation19
Options and derivatives0
Other securities0

Role architecture

Who is participating

Director29

Transaction evidence

Auditable ALGN filing ledger

Showing 1 to 29 of 29.

CONROY, KEVIN TDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
CONROY, KEVIN TDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
CONROY, KEVIN TDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
DALLAS, KEVIN JDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
DALLAS, KEVIN JDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
DALLAS, KEVIN JDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
LACOB, JOSEPHDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
LACOB, JOSEPHDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
LACOB, JOSEPHDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
LARKIN, C RAYMOND JRDirector
AcquisitionEquity compensation
2448 sharesRestricted Stock Units
Not reportedContext evidence
LARKIN, C RAYMOND JRDirector
AcquisitionCommon equity
2326 sharesCommon Stock
Not reportedContext evidence
LARKIN, C RAYMOND JRDirector
DisposalEquity compensation
2326 sharesRestricted Stock Units
Not reportedContext evidence
MORROW, GEORGE JDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
MORROW, GEORGE JDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
MYONG, ANNEDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
MYONG, ANNEDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
MYONG, ANNEDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
POUL, MOJDEHDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
POUL, MOJDEHDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
POUL, MOJDEHDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
SAIA, ANDREA LYNNDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
SAIA, ANDREA LYNNDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
SAIA, ANDREA LYNNDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
SIEGEL, SUSAN EDirector
AcquisitionCommon equity
1745 sharesCommon Stock
Not reportedContext evidence
SIEGEL, SUSAN EDirector
DisposalEquity compensation
1745 sharesRestricted Stock Units
Not reportedContext evidence
SIEGEL, SUSAN EDirector
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence
VITALONE, BRITT J.Director
AcquisitionCommon equity
1443 sharesCommon Stock
Not reportedContext evidence
VITALONE, BRITT J.Director
DisposalEquity compensation
1443 sharesRestricted Stock Units
Not reportedContext evidence
VITALONE, BRITT J.Director
AcquisitionEquity compensation
1836 sharesRestricted Stock Units
Not reportedContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context